Sophia Genetics
Series D+Sophia Genetics raised €26M in a Series D+ round in Jul 2017. The company is based in Saint-Sulpice, Switzerland. Investors in the round: 360 Capital Partners, Alychlo, Balderton Capital and 1 other. Data as of 4 Nov 2026.
Amount raised
€26M
€26,276,605
Native amount
30,000,000 USD
Stage
Series D+
series d
Investors
4
Provenance & confidence
High confidenceAmount
30,000,000 USD
ECB-at-date → €26M · rate 1.1417 on 2017-07-13
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Jul 2017
Round type
series d
Amount (EUR)
€26M